✦ LIBER ✦

Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome

✍ Scribed by Michael J. Romano; Gregory L. Kearns; Sheldon L. Kaplan; Richard F. Jacobs; Anthony Killian; John S. Bradley; M. Michele Moss; Russell Van Dyke; William Rodriguez; Richard C. Straube

Book ID: 117164317
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 765 KB
Volume: 122
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(09)90031-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reactivity of a human monoclonal anti-GM

Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures

✍ M.O. Jauberteau; I. Brindel; N. Baumann; J.L. Preud'homme 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 738 KB

Safety and pharmacokinetics of a human m

Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults

✍ Nithya Gogtay; Urmila Thatte; Nilima Kshirsagar; Brett Leav; Deborah Molrine; Pe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer

✍ Infante, Jeffrey R.; Bendell, Johanna C.; Goff, Laura Williams; Jones, Suzanne F 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 511 KB

A multicenter, open-label, prospective,

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

✍ James Gallagher; Charles Fisher; Bruce Sherman; Mark Munger; Bruce Meyers; Travi 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 133 KB

Dose escalation and pharmacokinetic stud

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

✍ Tokuda, Y; Watanabe, T; Omuro, Y; Ando, M; Katsumata, N; Okumura, A; Ohta, M; Fu 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

A dose finding, safety and pharmacokinet

A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours

✍ Soria, Jean Charles; Massard, Christophe; Lazar, Vladimir; Ozoux, Marie-Laure; M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 358 KB